List of works - Carlos Taxonera

2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases

scientific article published on 02 May 2020

Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.

scientific article published on 19 December 2016

Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.

scientific article

Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease ⬇️

scientific article published on December 14, 2011

Analysis of a non-synonymous single nucleotide polymorphism of the human diamine oxidase gene (ref. SNP ID: rs1049793) in patients with Crohn's disease

article

Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.

scientific article published on 12 January 2016

Differences in the need for adalimumab dose optimization between Crohn's disease and ulcerative colitis

scientific article published on 01 November 2019

Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis

scientific article published on 13 March 2019

Editorial: social distancing during the COVID-19 pandemic-IBD patients cannot stay at home forever. Authors' reply

scientific article published on 01 August 2020

Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent.

scientific article published on 2 March 2016

Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn's disease patients: the Practicrohn study

scientific article published on 17 June 2019

Erratum: Corrigendum: Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study

scientific article published in June 2016

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

scientific article published in August 2009

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease

scientific article published on 25 September 2019

GSTT1 and GSTM1 null genotypes may facilitate hepatitis C virus infection becoming chronic

scientific article published on 15 March 2007

Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use

scientific article

Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding

scientific article published on 01 January 2008

Letter: SARS-CoV-2 induced gastrointestinal inflammation-authors' reply

scientific article published on 01 December 2020

Letter: immunotherapy for IBD patients in a SARS-CoV-2 endemic area-authors' reply

scientific article published on 01 September 2020

Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors-authors' reply

scientific article published on 25 June 2020

Letter: severe COVID-19 infection and biologic therapies-a cohort study of 7808 patients in France. Authors' reply

scientific article published on 01 October 2020

Methotrexate in inflammatory bowel disease

scientific article published on 01 September 2012

Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy ⬇️

scientific article published on July 27, 2011

Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review

scientific article published on 27 July 2020

Reliability evaluation of four different assays for therapeutic drug monitoring of infliximab levels

scientific article published on 26 June 2018

List of works by Carlos Taxonera